- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Sleeping Through Surgery?
27 August 2002 (All day)
As grateful patients can attest, anesthesia lets people sleep through even the most drastic of operations. Now a study shows how a common type of anesthetic sends the brain to slumberland. The finding, reported online 26 August in Nature Neuroscience, could lead to new drugs with lower chances of side effects.
Some of the most widely used anesthetics act on receptors for the neurotransmitter GABA, a small molecule used primarily as an ‘off' switch by the brain. These so-called GABAergic anesthetics create something similar to non-REM sleep, the dark gulfs of inactivity between dreams. This type of sleep is thought to be triggered when the brain produces GABA to shut down a clump of neurons known as the tuberomammillary nucleus (TMN). The sleep-inducing TMN was suspected to be the prime target of the GABAergic anesthetics.
To test this idea, neuroscientist Nick Franks and colleagues at Imperial College, London, anesthetized mice in various ways. Before administering GABAergic anesthesia, they injected a drug called gabazine into the TMN. Gabazine blocks GABA and similar molecules from receptors, thus preventing the deactivation of neurons. As predicted, GABAergic anesthetics could not knock out the mice treated with gabazine. But when mice were knocked out with ketamine, a non-GABAergic anesthetic, they slept soundly with or without the injection of gabazine. This reveals that the TMN is a direct target of the GABAergic anesthetics, establishing a link between anesthesia and the brain's natural path to sleep.
The results impress Neil Harrison of Cornell University because they bridge the fields of anesthesia and neurophysiology. All general anesthetics pose a small health risk to patients, he says, but with this new insight, scientists may now be able to design drugs that render patients unconscious without the risk of upsetting their breathing or blood pressure.